Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin/Tazobactam in Obese Patients
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2018
Price : $35 *
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Bacterial infections; Obesity
- Focus Pharmacokinetics
- 13 Sep 2016 Status changed from active, no longer recruiting to completed.
- 02 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 22 Oct 2013 Planned initiation date changed from 1 Sep 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov record.